Polatuzumab vedotin plus bendamustine with rituximab in relapsed/refractory diffuse large B-cell lymphoma: Updated results of a phase Ib/II randomized study Meeting Abstract
| Authors: | Sehn, L. H.; Matasar, M. J.; Flowers, C. R.; Kamdar, M.; McMillan, A. K.; Hertzberg, M.; Assouline, S.; Kim, T. M.; Kim, W. S.; Ozcan, M.; Croft, B.; Hirata, J.; Cheng, J.; Ku, G.; Herrera, A. F. |
| Abstract Title: | Polatuzumab vedotin plus bendamustine with rituximab in relapsed/refractory diffuse large B-cell lymphoma: Updated results of a phase Ib/II randomized study |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577164602104 |
| DOI: | 10.1182/blood-2019-123449 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4081 -- Source: Wos |
